| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.49 | 0.08 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.38 | 0.05 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.33 | 0.03 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.22 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.18 | 0.4 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.18 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.18 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.004 |